We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
01 May 2019
The 2018 Federal Budget announced the creation of an Advisory Council on the Implementation of National Pharmacare (for further details please see "Federal Budget 2018 announces advisory council for national pharmacare programme"). On 6 March 2019 the advisory council delivered its interim report with three initial recommendations:
The advisory council indicated that the final report should be issued in the coming months.
On 19 March 2019 the federal government delivered the 2019 Federal Budget, which reflects these recommendations. In particular, the government plans to create:
While the mandate for the Canadian Drug Agency is still in development, it will "be able to provide impartial and independent advice so that drug evaluation and price negotiation could be carried out by a single, coordinated entity".
For further information on this topic please contact Brandon Heard at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (email@example.com). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.